These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 27838289)

  • 21. Progress in biopharmaceutical development.
    Kesik-Brodacka M
    Biotechnol Appl Biochem; 2018 May; 65(3):306-322. PubMed ID: 28972297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbial biotechnology.
    Demain AL
    Trends Biotechnol; 2000 Jan; 18(1):26-31. PubMed ID: 10631778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteins behaving badly: emerging technologies in profiling biopharmaceutical aggregation.
    Hamrang Z; Rattray NJ; Pluen A
    Trends Biotechnol; 2013 Aug; 31(8):448-58. PubMed ID: 23769716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in in-situ product recovery (ISPR) in whole cell biotechnology during the last decade.
    Van Hecke W; Kaur G; De Wever H
    Biotechnol Adv; 2014 Nov; 32(7):1245-1255. PubMed ID: 25072605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammalian cell culture capacity for biopharmaceutical manufacturing.
    Ecker DM; Ransohoff TC
    Adv Biochem Eng Biotechnol; 2014; 139():185-225. PubMed ID: 23748352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosimilars for the treatment of infectious diseases: the case of biosimilar interferons.
    El-Sherbeini M
    Drugs Today (Barc); 2011 Jun; 47(6):431-40. PubMed ID: 21695285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosimilars: current status and future directions.
    Roger SD
    Expert Opin Biol Ther; 2010 Jul; 10(7):1011-8. PubMed ID: 20384525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cumulative updating of approved biopharmaceuticals.
    Redwan el-RM
    Hum Antibodies; 2007; 16(3-4):137-58. PubMed ID: 18334749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic plants as factories for biopharmaceuticals.
    Giddings G; Allison G; Brooks D; Carter A
    Nat Biotechnol; 2000 Nov; 18(11):1151-5. PubMed ID: 11062432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopharmaceuticals: recent approvals and likely directions.
    Walsh G
    Trends Biotechnol; 2005 Nov; 23(11):553-8. PubMed ID: 16051388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Separation science is the key to successful biopharmaceuticals.
    Guiochon G; Beaver LA
    J Chromatogr A; 2011 Dec; 1218(49):8836-58. PubMed ID: 21982447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shifting Paradigms Revisited: Biotechnology and the Pharmaceutical Sciences.
    Crommelin DJA; Mastrobattista E; Hawe A; Hoogendoorn KH; Jiskoot W
    J Pharm Sci; 2020 Jan; 109(1):30-43. PubMed ID: 31449815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Process development for production of recombinant human interferon-gamma expressed in Escherichia coli.
    Khalilzadeh R; Shojaosadati SA; Maghsoudi N; Mohammadian-Mosaabadi J; Mohammadi MR; Bahrami A; Maleksabet N; Nassiri-Khalilli MA; Ebrahimi M; Naderimanesh H
    J Ind Microbiol Biotechnol; 2004 Feb; 31(2):63-9. PubMed ID: 14986150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fresh from the biotech pipeline--2013.
    Kling J
    Nat Biotechnol; 2014 Feb; 32(2):121-4. PubMed ID: 24509747
    [No Abstract]   [Full Text] [Related]  

  • 36. On the verge of the market - Plant factories for the automated and standardized production of biopharmaceuticals.
    Huebbers JW; Buyel JF
    Biotechnol Adv; 2021; 46():107681. PubMed ID: 33326816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compendium on Food Crop Plants as a Platform for Pharmaceutical Protein Production.
    Gerszberg A; Hnatuszko-Konka K
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of biosimilars for the future.
    Johnson PE
    Am J Health Syst Pharm; 2008 Jul; 65(14 Suppl 6):S16-22. PubMed ID: 18591711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of the nonclinical quality and toxicology testing for recombinant biopharmaceuticals produced in mammalian cells.
    Lebrec H; Narayanan P; Nims R
    J Appl Toxicol; 2010 Jul; 30(5):387-96. PubMed ID: 20589744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein crystals for the delivery of biopharmaceuticals.
    Basu SK; Govardhan CP; Jung CW; Margolin AL
    Expert Opin Biol Ther; 2004 Mar; 4(3):301-17. PubMed ID: 15006725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.